Eco R1 Capital, LLC Crispr Therapeutics Ag Transaction History
Eco R1 Capital, LLC
- $2.14 Billion
- Q4 2024
A detailed history of Eco R1 Capital, LLC transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Eco R1 Capital, LLC holds 1,389,276 shares of CRSP stock, worth $57.3 Million. This represents 2.55% of its overall portfolio holdings.
Number of Shares
1,389,276
Previous 1,389,276
-0.0%
Holding current value
$57.3 Million
Previous $65.3 Million
16.24%
% of portfolio
2.55%
Previous 2.83%
Shares
10 transactions
Others Institutions Holding CRSP
# of Institutions
488Shares Held
64.1MCall Options Held
1.64MPut Options Held
1.93M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl8.97MShares$370 Million3.09% of portfolio
-
Capital International Investors Los Angeles, CA8.74MShares$360 Million0.07% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.81MShares$157 Million0.09% of portfolio
-
Black Rock Inc. New York, NY2.78MShares$115 Million0.0% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.2.75MShares$113 Million0.07% of portfolio
About CRISPR Therapeutics AG
- Ticker CRSP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,009,296
- Market Cap $3.22B
- Description
- CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....